Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Ketki Bhise"'
Autor:
Aaron Goldman, Ketki Bhise, Chunxiao (Emma) Cui, Kirti Khardenavis, Anthony Attardo, Danielle Hagee, Sinal Patel, Julia Vail, Amir Aref, Nicholas Barris, Alyssa Martin, Michael A Perricone
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/64752b4b365a4801ac72c0fd0320ac0f
Autor:
Mohd Ahmar Rauf, Munazzah Tasleem, Ketki Bhise, Katyayani Tatiparti, Samaresh Sau, Arun K. Iyer
Publikováno v:
View, Vol 2, Iss 3, Pp n/a-n/a (2021)
Abstract The coronaviruses have caused severe acute respiratory syndrome (SARS), the Middle East respiratory syndrome (MERS), and the more recent coronavirus pneumonia (COVID‐19). The global COVID‐19 pandemic requires urgent action to develop ant
Externí odkaz:
https://doaj.org/article/4a949c7ba568402ea6db53e89e7e9a14
Autor:
Kushal Vanamala, Ketki Bhise, Hiram Sanchez, Razieh Kebriaei, Duy Luong, Samaresh Sau, Hosam Abdelhady, Michael J. Rybak, David Andes, Arun K. Iyer
Publikováno v:
Pharmaceutics, Vol 13, Iss 11, p 1791 (2021)
Methicillin-resistant Staphylococcus aureus (MRSA), commonly called a superbug, is a highly alarming antibiotic-resistant population of Staphylococcus aureus (S. aureus) bacteria. Vancomycin (VAN) was first approved by the FDA in 1988, and it is stil
Externí odkaz:
https://doaj.org/article/1391a5fd18734e85bf0de9c19fde62e1
Autor:
Hashem O. Alsaab, Samaresh Sau, Rami Alzhrani, Katyayani Tatiparti, Ketki Bhise, Sushil K. Kashaw, Arun K. Iyer
Publikováno v:
Frontiers in Pharmacology, Vol 8 (2017)
Several cancers are highly refractory to conventional chemotherapy. The survival of tumors in several cases is assisted by checkpoint immunomodulation to maintain the imbalance between immune surveillance and cancer cell proliferation. Check point an
Externí odkaz:
https://doaj.org/article/c567f46421d34fa8a7945bf6007eff5a
Autor:
Alex Petrovici, Kushal Vanamala, Samaresh Sau, Arun K. Iyer, Matthew J. Krinock, Hashem O. Alsaab, Rami Alzhrani, Ketki Bhise
Publikováno v:
Drug Discov Today
The delivery of noncoding (nc)RNA to target cancer stem cells and metastatic tumors has shown many positive outcomes, resulting in improved and more efficient treatment strategies. The success of therapeutic RNA depends solely on passing cellular bar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78050a8d2386da52a4ff29a369752b21
https://doi.org/10.1016/j.drudis.2019.11.006
https://doi.org/10.1016/j.drudis.2019.11.006
Autor:
Ketki Bhise, Katyayani Tatiparti, Somrita Dey, Kushal Vanamala, Ayatakshi Barari, Samaresh Sau, Arun K. Iyer
Publikováno v:
Organelle and Molecular Targeting ISBN: 9781003092773
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d775158ce5aee11b366c63ba9b51a97
https://doi.org/10.1201/9781003092773-20
https://doi.org/10.1201/9781003092773-20
Autor:
Hosam Gharib Abdelhady, Arun K. Iyer, Hiram Sanchez, Razieh Kebriaei, Duy Luong, Ketki Bhise, Samaresh Sau, Michael J. Rybak, Kushal Vanamala, David R. Andes
Publikováno v:
Pharmaceutics
Volume 13
Issue 11
Pharmaceutics, Vol 13, Iss 1791, p 1791 (2021)
Volume 13
Issue 11
Pharmaceutics, Vol 13, Iss 1791, p 1791 (2021)
Methicillin-resistant Staphylococcus aureus (MRSA), commonly called a superbug, is a highly alarming antibiotic-resistant population of Staphylococcus aureus (S. aureus) bacteria. Vancomycin (VAN) was first approved by the FDA in 1988, and it is stil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4739d534fc10dd5bb2f20d2e5e6a9493
Autor:
Ayatakshi Barari, Samaresh Sau, Hashem O. Alsaab, Kushal Vanamal, Ketki Bhise, Arun K. Iyer, Rami Alzhrani, Katyayani Tatiparti
Publikováno v:
Adv Ther (Weinh)
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive disease with the lowest survival rate among all solid tumors. The lethality of PDAC arises from late detection and propensity of the tumor to metastasize and develop resistance against ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5212fda7e4e79fabed56ab3c3a4a633
https://pubmed.ncbi.nlm.nih.gov/34212073
https://pubmed.ncbi.nlm.nih.gov/34212073
Publikováno v:
Nanomedicine. 14:1515-1519
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c569bd0d50f93f1942cee776d2255c4e
https://doi.org/10.2217/nnm-2019-0109
https://doi.org/10.2217/nnm-2019-0109
Publikováno v:
Drug Discovery Today. 24:462-491
Cancer is the second highest cause of death worldwide. Several therapeutic approaches, such as conventional chemotherapy, antibodies and small molecule inhibitors and nanotherapeutics have been employed in battling cancer. Amongst them, nanotheranost
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8341eedc5a276bbdc1c78a2891e5bd72
https://doi.org/10.1016/j.drudis.2018.08.009
https://doi.org/10.1016/j.drudis.2018.08.009